Go Pro
NASDAQ:MMSI

Merit Medical Systems Q2 2026 Earnings Report

Merit Medical Systems logo
$69.45 +0.11 (+0.16%)
Closing price 04:00 PM Eastern
Extended Trading
$69.44 -0.02 (-0.02%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems EPS Results

Actual EPS
N/A
Consensus EPS
$0.96
Beat/Miss
N/A
One Year Ago EPS
N/A

Merit Medical Systems Revenue Results

Actual Revenue
N/A
Expected Revenue
$405.27 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Merit Medical Systems Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Wednesday, July 29, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

Merit Medical Systems Earnings Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Merit Medical Systems, Inc.
See More Merit Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Merit Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merit Medical Systems and other key companies, straight to your email.

About Merit Medical Systems

Merit Medical Systems (NASDAQ:MMSI) is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach. Headquartered in South Jordan, Utah, the company operates manufacturing and distribution facilities in North America, Europe and Asia. Merit’s products are sold in over 90 countries worldwide, with regional sales offices in Europe, Latin America and the Asia‐Pacific region to support local clinical training and customer service.

Under the leadership of founder and CEO Fred Lampropoulos, Merit Medical Systems has maintained a focus on innovation, quality and customer education. The company invests in research and development to evolve its product pipeline and partners with healthcare professionals to improve procedural outcomes. Merit’s commitment to minimally invasive care and patient safety has positioned it as a key supplier to hospitals and health systems seeking advanced device solutions for complex diagnostic and therapeutic procedures.

View Merit Medical Systems Profile